Jon Weidanz, Ph.D.

Dr. Weidanz has over 20 years of experience in biotechnology research with emphasis in immunology, immunotherapy and immunodiagnostic product development, especially as these disciplines relate to oncology and the development of products to diagnose and treat cancer. His work has been funded from the NIH, DOD and American Heart Association. He is the founder and Chief Scientific Officer of Receptor Logic, Inc., and most recently served as its President. His other duties include serving as: 1) Chairman for the Department of Immunotherapeutics and Biotechnology, 2) Director for the Center for Immunotherapeutic Research and Product Development, and 3) a tenured Professor at Texas Tech University Health Sciences Center (TTUHSC). He received the President's Excellence in Teaching Award as well as the Chancellor's Council Distinguished Teaching Award for his innovative classroom instruction TTUHSC.

External Link (www.ttuhsc.edu)